methylcellulose

Botanicalexperimental

Hypromellose (INN), short for hydroxypropyl methylcellulose (HPMC), is a semisynthetic, inert, viscoelastic polymer used in eye drops, as well as an excipient and controlled-delivery component in oral medicaments, found in a variety of commercial products. — Wikipedia

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • celevac
  • cellucon
  • cellulose methyl
  • cellulose methylate
  • cellulose methyl ether
  • citrucel
  • cologel
  • cologel
  • methocel a
  • methocel a
  • methycellulose
  • methylated cellulose
  • methylated cellulose
  • methylcellulose
  • methylcellulose
  • methylcellulose
  • methylcellulose
  • methylcellulose
  • methyl cellulose
  • methylcellulosum
  • methylcellulosum
  • metilcelulosa
  • metilcelulosa
  • nilstim

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06962462N/AMay 5, 2025South Valley University
NCT07194447N/AOct 3, 2024University of Baghdad
NCT06514586Phase 3Sep 30, 2024Government of Saudi Arabia
NCT06551961N/AAug 9, 2024University of East Anglia, University of Nottingham
NCT06361108Phase 1May 16, 2024Hanmi Pharmaceutical
NCT06551948N/AJan 1, 2024University of East Anglia, University of Nottingham
NCT06291272N/AOct 15, 2023Quadram Institute, University of Nottingham
NCT05999630Phase 3Aug 21, 2023Vanderbilt University
NCT05911347N/AMay 9, 2023University of East Anglia, University of Nottingham
NCT05451667Phase 1Aug 15, 2022Government of China
NCT06221345Phase 4Dec 7, 2021Chang Gung University
NCT04871360N/AMay 5, 2021Universidad de Guanajuato
NCT05924893N/AJan 1, 2021Minia University
NCT04252209Phase 3Mar 31, 2020Cairo University
NCT03452891Phase 4Jul 1, 2018University of Nebraska
NCT03575130Phase 2Jun 5, 2018University of Erlangen-Nuremberg
NCT03484507Phase 2Jan 1, 2018University of California, San Francisco
NCT04951869Phase 2/Phase 3 (Phase 3)Apr 26, 2017National University of Malaysia
NCT02845336Phase 2Mar 5, 2017Johns Hopkins University
NCT03380624Phase 4Mar 1, 2017Allergan, Ohio State University
Showing 20 of 42 trials
Page 1 / 3

Organizations

Research & Development (59)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of NottinghamAcademic/Hospital4412023
Harvard UniversityAcademic/Hospital3222008
ORA, Inc.For profit3122008
University of East AngliaAcademic/Hospital3012023
AllerganFor profit2122007
Ohio State UniversityAcademic/Hospital2122015
University of NebraskaAcademic/Hospital2222010
Aga Khan UniversityAcademic/Hospital1112007
Bascom Palmer Eye InstituteAcademic/Hospital1012009
Berhan Public Health and Eye Care Consultancy PLCAcademic/Hospital1012013
Biotechnology Institute IMASDAcademic/Hospital1112016
Cairo UniversityAcademic/Hospital1112020
Chang Gung UniversityAcademic/Hospital1112021
Clinica Oftamologica Zona SulAcademic/Hospital1112009
Edward Holland, MDAcademic/Hospital1112014
Georgetown UniversityAcademic/Hospital1112016
Glaucoma Research Society of CanadaAcademic/Hospital1012007
GlaxoSmithKlineFor profit1012014
Government of ChinaGovernment1112022
Government of Saudi ArabiaGovernment1112024
59 organizations
Page 1 / 3